M Health Fairview Ridges Hospital

Summary

M Health Fairview Ridges Hospital is a medical facility located in Burnsville, Minnesota. This center is recognized for care of Stroke, I Am A Healthy Volunteer, Coronavirus, Ischemic Stroke, COVID-19 and other specialties. M Health Fairview Ridges Hospital is involved with conducting 4 clinical trials across 13 conditions. There are 1 research doctors associated with this hospital, such as Christopher Streib, MD.

Top PIs

Clinical Trials running at M Health Fairview Ridges Hospital

Stroke

Ischemic Stroke

Milvexian

for Stroke

This trial is testing whether milvexian can help prevent another stroke in people who have already had one by stopping blood clots from forming. Milvexian may reduce the risk of stroke without significant bleeding.

Recruiting

1 award

Phase 3

5 criteria

Recombinant Factor VIIa

for Hemorrhagic Stroke

The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy. FASTEST Part 2 is an extension of the FASTEST Trial where the subgroups include only those treated within 2 hours with a positive spot sign on a baseline CT angiogram.

Recruiting

1 award

Phase 3

2 criteria

TS23

for Stroke

SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.

Recruiting

0 awards

Phase 2